• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Boston Scientific (NY: BSX )

    86.44 UNCHANGED
    Streaming Delayed Price Updated: 7:00 PM EST, Nov 6, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Boston Scientific

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    14 15 Next >
    Why is Boston Scientific Stock Trading Lower On Wednesday?
    Boston Scientific's ACURATE IDE trial results showed a 16.16% composite rate for mortality, stroke, or rehospitalization, not meeting non-inferiority versus controls. 
    Via Benzinga
    $1000 Invested In This Stock 15 Years Ago Would Be Worth $11,000 Today
    Via Benzinga
    Stock Market Mixed But Nasdaq Hits Record High As Tesla Leads Earnings Winners: Weekly Review
    The major indexes were mixed for the week. 
    Via Investor's Business Daily
    Boston Scientific Pauses Enrollment In Farapulse Study In Drug-Naive Patients With Irregular Heart Rhythm
    Boston Scientific's AVANT GUARD trial evaluates the FARAPULSE PFA System for treating persistent atrial fibrillation, pausing enrollment to assess trial observations. 
    Via Benzinga
    Behind the Scenes of Boston Scientific's Latest Options Trends
    Via Benzinga
    Boston Scientific Earnings, Sales Top Q3 Views; Stock Eyes High
    The medtech giant beat on the top and bottom line early Wednesday. 
    Via Investor's Business Daily
    Boston Scientific's Options Frenzy: What You Need to Know
    Via Benzinga
    Wall Street Slumps For Third Straight Day As Investor Sentiment Fades, Dollar Strength Resumes, Boeing Disappoints: What's Driving Markets Wednesday?
    Wall Street is on track for its third consecutive day of losses as investors grow cautious about risky assets, awaiting more clarity on U.S. fiscal and monetary policies and scrutinizing the latest... 
    Via Benzinga
    Boston Scientific Q3 Earnings: Revenue And EPS Beat, Lifts Annual Forecast On Strong Demand For Heart Devices
    Boston Scientific exceeded Q3 expectations with $4.21 billion revenue and $0.63 EPS. Cardiovascular sales rose 25%, and 2024 growth guidance was updated. 
    Via Benzinga
    Critical Insights From Boston Scientific Analyst Ratings: What You Need To Know
    Via Benzinga
    Key Takeaways From Boston Scientific Analyst Ratings
    Via Benzinga
    Performance Comparison: Boston Scientific And Competitors In Health Care Equipment &amp; Supplies Industry
    Via Benzinga
    Is BOSTON SCIENTIFIC CORP Ready to Break Out of Its Range?
    BOSTON SCIENTIFIC CORP (NYSE:BSX) has a good technical rating of 10 out of 10 and could possibly break out. 
    Via Chartmill
    US Hospitals Face Critical IV Fluid Shortage After Baxter Facility Shuts Down Due To Hurricane Helene
    The U.S. faces a critical shortage of IV fluids due to Hurricane Helene's damage to Baxter's North Carolina plant, forcing hospitals to delay surgeries. Federal efforts to rebuild and import supplies... 
    Via Benzinga
    This Boston Scientific Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
    Via Benzinga
    Solventum Stock Earns 81 RS Rating
    Solventum stock saw a positive improvement to its Relative Strength Rating on Tuesday, with an upgrade from 78 to 81. 
    Via Investor's Business Daily
    Here's How Much You Would Have Made Owning Boston Scientific Stock In The Last 10 Years
    Via Benzinga
    18 Stocks To Buy, 7 To Sell This Earnings Season: Goldman Sachs Calls It 'The Year Of The Stock Picker'
    Goldman Sachs identifies 18 stocks for potential earnings upside and advises options-based strategies in a volatile market. 10% upside for S&P 500. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    If You Invested $1000 In This Stock 15 Years Ago, You Would Have $8,100 Today
    Via Benzinga
    Boston Scientific: Why This MedTech Giant Isn’t Slowing Down
    Boston Scientific Co (NYSE: BSX) is a global medical device manufacturer that’s seeing a strong influx of investors as shares grind to new all-time highs. 
    Via MarketBeat
    Here's How Much You Would Have Made Owning Boston Scientific Stock In The Last 10 Years
    Via Benzinga
    Medtronic Stock: Growth On Rise of the Cardiovascular Machines
    Medtronic is a leading global medical device maker in the medical sector. Its innovative and critical medical device portfolio addresses chronic diseases 
    Via MarketBeat
    Growth At Any Price (GAAP) Is A Bad Strategy. Valuation Matters.
    The current leadership in the stock market is clearly not tech, or the Magnificent 7. 
    Via Talk Markets
    Spotlight on Boston Scientific: Analyzing the Surge in Options Activity
    Via Benzinga
    If You Invested $1000 In This Stock 15 Years Ago, You Would Have $6,900 Today
    Via Benzinga
    In-Depth Examination Of 18 Analyst Recommendations For Boston Scientific
    Via Benzinga
    Here's How Much $1000 Invested In Boston Scientific 10 Years Ago Would Be Worth Today
    Via Benzinga
    This Is Great News for Medtronic, but Is It Time to Buy the Stock?
    This MedTech leader is back on track with profitable growth. 
    Via The Motley Fool
    Boston Scientific Continues Bullish Sequence
    Boston Scientific Corporation (BSX​​​​​​​) develops, manufactures & markets medical devices for use in various interventional medical specialties worldwide. It operates through MedSurg & Cardiovascular... 
    Via Talk Markets
    NYSE:BSX Shows Potential for a Breakout.
    A technical analysis of BOSTON SCIENTIFIC CORP (NYSE:BSX) shows it may be setting up for a breakout. 
    Via Chartmill
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    14 15 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.